Press Releases

• Industry veteran Mike Kanan has joined Particle Dynamics as the new Chief Financial Officer.

   

• Mike brings more than 30 years’ strategic finance experience across the pharma, life sciences, and industrial sectors, including significant tenures at Avadel Pharmaceuticals and industry titan Sigma Aldrich, now part of Merck Group.

   

• This addition to the Particle Dynamics leadership team will enhance operational efficiencies and drive strategic initiatives, including expanding and strengthening its global standing as a provider of GMP-quality oral solid dosage solutions.

   

St Louis - Particle Dynamics, a leader in oral solid dosage (OSD) technologies for the pharmaceutical sector, has announced the appointment of industry veteran Mike Kanan as its new Chief Financial Officer. Mike's appointment marks a significant milestone for Particle Dynamics, underscoring the company’s commitment to delivering enhanced value to clients and stakeholders.

With more than 30 years’ finance experience spanning private equity-owned and public companies including industry giant Sigma Aldrich, acquired by Merck KGaA in 2015, Mike brings a wealth of knowledge and expertise to his new role at Particle Dynamics. His proven track record in financial leadership and strategic planning will be instrumental in driving Particle Dynamics’ continued growth and success in the pharmaceutical and healthcare industries.

As well as overseeing the finance function, Mike will work with the executive team to develop and implement strategic initiatives aimed at enhancing operational efficiency and driving growth across the organization.

Nicolas Fortin, CEO of Particle Dynamics, said: “Mike’s extensive experience and financial leadership make him the ideal candidate to lead our finance team during this exciting period of growth and expansion. I am confident Mike’s strategic vision will be invaluable as we continue to strengthen our position as a global leader in particle processing and delivery technologies."

In addition to his six years at Sigma Aldrich as Vice President of Finance and Corporate Controller, Mike served at Avadel Pharmaceuticals as Chief Financial Officer, a publicly traded specialty pharma company.

Mike added: "I look forward to working with the talented team at Particle Dynamics at a pivotal time in the company’s growth trajectory and collaborating with them to drive financial excellence, foster innovation, and deliver value to our customers and stakeholders.”

ENDS

About Particle Dynamics